Maestros Mediline Systems Ltd

Maestros Medi. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Maestros Mediline Systems Ltd

₹ 10.4 -1.97%
30 Mar 2015
Company website BSE: 501209
About

Maestros is India's leading medical diagnostic equipment and services organizations, which focuses on empowering medical professionals and institutions, that treat cardiac, gynecology and critical care patients across the country.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 10.4
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -88.5
  • Dividend Yield %
  • ROCE -18.5 %
  • ROE %
  • Face Value ₹
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -57.2% over past five years.
  • Company has high debtors of 1,219 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014
2.81 3.44 1.97 0.26 0.88 1.09 1.07 4.38
8.59 4.41 0.05 0.36 2.11 0.58 1.76 5.41
Operating Profit -5.78 -0.97 1.92 -0.10 -1.23 0.51 -0.69 -1.03
OPM % -205.69% -28.20% 97.46% -38.46% -139.77% 46.79% -64.49% -23.52%
0.47 0.00 0.00 0.02 0.03 0.00 0.00 0.00
Interest 1.61 0.18 0.01 0.00 0.13 0.00 0.01 0.02
Depreciation 0.92 0.48 0.51 0.48 0.25 0.18 0.19 0.19
Profit before tax -7.84 -1.63 1.40 -0.56 -1.58 0.33 -0.89 -1.24
Tax % -0.89% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-7.77 -1.63 1.40 -0.57 -1.58 0.32 -0.89 -1.24
EPS in Rs -17.66 -3.70 3.18 -1.30 -3.59 0.73 -2.02 -2.82
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
20.70 25.02 33.76 27.58 28.15 39.07 32.26 9.82 7.02 4.23 0.56
17.38 21.69 29.50 24.11 24.57 31.98 24.93 18.97 19.59 25.74 2.98
Operating Profit 3.32 3.33 4.26 3.47 3.58 7.09 7.33 -9.15 -12.57 -21.51 -2.42
OPM % 16.04% 13.31% 12.62% 12.58% 12.72% 18.15% 22.72% -93.18% -179.06% -508.51% -432.14%
-0.05 -0.06 0.27 0.59 0.94 0.79 0.22 0.75 -0.72 0.04 0.14
Interest 0.68 0.79 1.59 1.83 2.39 2.94 4.00 5.38 0.37 0.03 0.02
Depreciation 2.06 1.76 1.26 1.24 1.73 2.34 1.81 1.88 1.00 0.79 0.70
Profit before tax 0.53 0.72 1.68 0.99 0.40 2.60 1.74 -15.66 -14.66 -22.29 -3.00
Tax % 20.75% 20.83% 25.60% 79.80% 45.00% 3.85% -8.62% -7.98% 0.00% 0.00% 0.00%
0.42 0.57 1.25 0.20 0.22 2.50 1.88 -14.41 -14.66 -22.29 -3.00
EPS in Rs 0.45 0.50 5.68 4.27 -32.75 -33.32 -50.66 -6.82
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -30%
5 Years: -57%
3 Years: -62%
TTM: -87%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 21%
TTM: 87%
Stock Price CAGR
10 Years: 0%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Equity Capital 4.55 4.55 4.55 4.42 4.37 4.37 4.37 4.37 4.37 4.37 4.37
Reserves 29.81 30.38 31.63 31.38 31.44 33.94 11.84 -2.58 -17.23 -40.30 -43.30
3.91 10.47 4.39 7.79 7.50 11.73 37.08 49.67 51.05 53.40 53.67
9.44 14.56 18.53 23.35 25.70 23.73 19.25 23.01 19.64 5.38 7.26
Total Liabilities 47.71 59.96 59.10 66.94 69.01 73.77 72.54 74.47 57.83 22.85 22.00
24.17 23.03 23.10 27.98 28.16 31.13 15.23 14.39 13.45 11.88 11.19
CWIP 0.00 0.33 0.18 0.36 0.00 0.00 7.40 0.00 0.00 0.00 0.00
Investments 0.38 0.31 4.61 1.03 1.03 1.54 0.73 0.73 0.01 0.01 0.01
23.16 36.29 31.21 37.57 39.82 41.10 49.18 59.35 44.37 10.96 10.80
Total Assets 47.71 59.96 59.10 66.94 69.01 73.77 72.54 74.47 57.83 22.85 22.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
4.17 -4.19 13.34 7.28 3.28 2.59 -5.93 -9.51 0.48 -0.27 0.03
-0.63 -1.01 -5.46 -2.57 -1.54 -5.83 -14.55 -1.57 0.42 -0.38 0.11
-3.31 5.80 -7.48 0.98 -2.88 1.29 21.96 7.48 -0.25 -0.14 0.04
Net Cash Flow 0.23 0.60 0.40 5.69 -1.14 -1.95 1.48 -3.60 0.65 -0.79 0.18

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Debtor Days 149.00 162.66 152.55 141.47 151.83 126.21 238.85 832.21 1,299.86 220.90 1,218.84
Inventory Days 256.05 216.70 159.19 233.80 279.17 237.67 414.11 441.86 67.26 40.16 69.30
Days Payable 103.45 113.55 113.52 174.26 239.63 146.33 293.15 364.27 250.74 106.40 1,538.54
Cash Conversion Cycle 301.60 265.81 198.22 201.01 191.37 217.55 359.80 909.80 1,116.37 154.66 -250.40
Working Capital Days 250.03 320.51 140.23 127.58 141.98 158.82 298.58 1,291.25 1,192.75 358.96 1,303.57
ROCE % 3.92% 7.63% 6.70% 6.42% 11.89% 11.11% -19.63% -30.27% -79.99% -18.50%

Shareholding Pattern

Numbers in percentages

Jun 2016Sep 2016
49.64% 49.64%
1.49% 1.49%
48.87% 48.87%
No. of Shareholders 1,2171,217

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports